$GLRE

GREENLIGHT CAPITAL RE, LTD. (GLRE): Results of Operations and Financial Condition

GREENLIGHT CAPITAL RE, LTD. (GLRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 3 pressreleaseearnings2026q2.htm EX-99.1 Document GREENLIGHT RE ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2026 Repurchases $14.2 million of ordinary shares GRAND CAYMAN, Cayman Islands – August 4, 2026 – Greenlight Capital Re, Ltd. (NASD

Original reporting
Published Aug 4, 2026, 8:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$GLRE
Bearish
medium confidence
Mentioned
$GLRE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GLREBearishMed
01

Why it matters

Traders can use the disclosed underwriting metrics (combined ratio, underwriting income/loss) and investment results (investment loss) to update expectations for near-term profitability and book value trajectory, with an earnings call scheduled for Aug 5.

02

Market read

The filing discloses a net loss, higher combined ratio driven by CAT losses, and a larger investment loss versus the prior year, alongside ongoing share repurchases.

03

What to watch

Share repurchases at an average cost near the mid-teens and BVPS stability over six months (up 0.9% to $20.61) could partially offset the negative Q2 optics.

Relevance 7/10Novelty 7/10Timing: after-hours filing today, ahead of the Aug 5 earnings call

Background

This is an SEC 8-K with an attached earnings press release for Greenlight Capital Re’s second quarter and six months ended June 30, 2026.

Company-level read

Ticker impact

$GLREBearishMedium confidence
Context

Greenlight Capital Re reported Q2 2026 results with a net loss of $29.6M, a 100.1% combined ratio, and $23.8M investment loss.

Expected impact

Likely negative bias for the next session as traders reprice underwriting CAT exposure and investment mark-to-market risk.

Evidence & confidence

The filing provides concrete quarterly datapoints: underwriting loss versus prior-year income, investment loss versus prior-year loss, and a 3.7% BVPS decline from March 31, 2026. No offsetting guidance or capital action beyond buybacks is disclosed in the excerpt.

Market effects

Reinsurance names may see read-across pressure when CAT losses and investment drawdowns coincide in the same quarter.

Limited direct regional impact; Cayman/Ireland/Lloyd’s platform results are company-specific.

Global reinsurance sentiment could soften if macro drag and investment losses persist across peers, but this is not a sector-wide catalyst.

Counterpoint

The company highlights discipline and prudent Middle East exposure with additional reserves, suggesting losses may be contained rather than structural.

Key entities

  • Greenlight Capital Re, Ltd.

    NASDAQ-listed reinsurance company reporting Q2 2026 financial results and buybacks.

  • Greg Richardson

    CEO quoted on volatility, Middle East exposure, and capital management.

  • David Einhorn

    Chairman quoted on investment period challenges and macro drag.

Related articles

$GLREMed

Greenlight Capital Re Q2 Earnings Call Highlights

Greenlight Capital Re (NASDAQ:GLRE) discussed its Q2 earnings call, focusing on specialty lines in marine and aviation and expecting meaningful losses tied to the Middle East conflict and the Ukraine war. The company reported a $23.8 million net investment loss, mainly from the Solasglas portfolio. Innovation segment underwriting profit improved, and Solasglas returned 4.9% in July.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.